Lista de obras - Juan Fueyo - Dominio Público Uruguay

A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation

artículo científico publicado en 2006

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo

artículo científico

A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes ⬇️

artículo científico publicado el 1 de junio de 1998

Adenovirus's last trick: you say lysis, we say autophagy

artículo científico publicado en 2007

Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter

artículo científico publicado en 2007

Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy ⬇️

artículo científico publicado el 1 de marzo de 1998

Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro ⬇️

artículo científico publicado el 23 de octubre de 1997

Advances in translational research in neuro-oncology

artículo científico publicado en 2010

Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells

artículo científico publicado en 2016

Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes

artículo científico publicado en 2014

Autophagy pathways in glioblastoma

artículo científico publicado en 2009

Autophagy regulation in cancer development and therapy ⬇️

artículo científico publicado el 25 de enero de 2010

Characterization of p53 and p21 Functional Interactions in Glioma Cells en Route to Apoptosis ⬇️

artículo científico publicado el 16 de julio de 1997

Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas

artículo científico publicado en 2005

Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens

artículo científico publicado en 2016

Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death

artículo científico publicado en 2008

Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model

artículo científico publicado en 2014

Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET

artículo científico publicado en 2020

Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses

artículo científico publicado en 2005

E2F1 and telomerase: alliance in the dark side

artículo científico publicado en 2006

E2F1 in gliomas: a paradigm of oncogene addiction

artículo científico publicado en 2008

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

scientific article published on 08 April 2022

Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas

artículo científico publicado en 2011

Genetically modified adenoviruses against gliomas: from bench to bedside

artículo científico publicado en 2004

Guidelines for the use and interpretation of assays for monitoring autophagy

artículo científico publicado en 2012

Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity

artículo científico publicado en 2011

Interspecies adenovirus fiber shows "evolutionary" advantage for oncolytic therapy of gliomas

artículo científico publicado en 2008

Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas

artículo científico publicado en 2019

Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model.

artículo científico publicado en 2015

Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination

artículo científico publicado en 2017

Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints

artículo científico publicado en 2015

Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas

artículo científico publicado en 2009

Oncolytic adenoviruses as antiglioma agents

artículo científico publicado en 2006

Oncolytic adenoviruses for malignant glioma therapy ⬇️

artículo científico publicado el 1 de mayo de 2003

Oncolytic adenoviruses for the treatment of brain tumors

artículo científico publicado el 1 de octubre de 2010

Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas

artículo científico publicado en 2006

Overexpression of E2F‐1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo ⬇️

artículo científico publicado el 1 de junio de 1998

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway ⬇️

artículo científico publicado el 7 de mayo de 2003

RB-E2F1: molecular rheostat for autophagy and apoptosis

artículo científico publicado en 2010

RTRB-10TYROSINE KINASE RECEPTOR TIE2 REGULATES DNA REPAIR THROUGH THE PROTO-ONCOGENE ABL1 IN BRAIN TUMOR STEM CELLS.

artículo científico publicado en 2015

Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma

artículo científico publicado en 2016

Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas

artículo científico publicado en 2016

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer ⬇️

artículo científico publicado el 1 de mayo de 1998

Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth

artículo científico publicado en 2006

TGF-β Mediates Homing of Bone Marrow–Derived Human Mesenchymal Stem Cells to Glioma Stem Cells ⬇️

artículo científico publicado el 30 de enero de 2013

TIE2 associates with caveolae and regulates caveolin-1 to promote their nuclear translocation

artículo científico publicado en 2017

TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1.

artículo científico publicado en 2016

Targeting brain tumor stem cells with oncolytic adenoviruses

artículo científico publicado en 2012

The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells

artículo científico publicado en 2011

The RB-E2F1 pathway regulates autophagy.

artículo científico publicado en 2010

The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity

artículo científico publicado en 2014

Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype

artículo científico publicado en 2010

VEGF Trap induces antiglioma effect at different stages of disease

scientific article published on 14 August 2008

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

artículo científico publicado en 2016

Lista de obras de Juan Fueyo

A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo

A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes ⬇️

Adenovirus's last trick: you say lysis, we say autophagy

Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter

Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy ⬇️

Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro ⬇️

Advances in translational research in neuro-oncology

Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells

Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes

Autophagy pathways in glioblastoma

Autophagy regulation in cancer development and therapy ⬇️

Characterization of p53 and p21 Functional Interactions in Glioma Cells en Route to Apoptosis ⬇️

Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas

Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens

Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death

Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model

Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET

Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses

E2F1 and telomerase: alliance in the dark side

E2F1 in gliomas: a paradigm of oncogene addiction

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas

Genetically modified adenoviruses against gliomas: from bench to bedside

Guidelines for the use and interpretation of assays for monitoring autophagy

Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity

Interspecies adenovirus fiber shows "evolutionary" advantage for oncolytic therapy of gliomas

Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas

Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model.

Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination

Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints

Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas

Oncolytic adenoviruses as antiglioma agents

Oncolytic adenoviruses for malignant glioma therapy ⬇️

Oncolytic adenoviruses for the treatment of brain tumors

Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas

Overexpression of E2F‐1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo ⬇️

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway ⬇️

RB-E2F1: molecular rheostat for autophagy and apoptosis

RTRB-10TYROSINE KINASE RECEPTOR TIE2 REGULATES DNA REPAIR THROUGH THE PROTO-ONCOGENE ABL1 IN BRAIN TUMOR STEM CELLS.

Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma

Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer ⬇️

Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth

TGF-β Mediates Homing of Bone Marrow–Derived Human Mesenchymal Stem Cells to Glioma Stem Cells ⬇️

TIE2 associates with caveolae and regulates caveolin-1 to promote their nuclear translocation

TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1.

Targeting brain tumor stem cells with oncolytic adenoviruses

The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells

The RB-E2F1 pathway regulates autophagy.

The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity

Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype

VEGF Trap induces antiglioma effect at different stages of disease

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)